» Articles » PMID: 36169756

Optimal MoCA Cutoffs for Detecting Biologically-defined Patients with MCI and Early Dementia

Overview
Journal Neurol Sci
Specialty Neurology
Date 2022 Sep 28
PMID 36169756
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In this phase II psychometric study on the Montreal cognitive assessment (MoCA), we tested the clinicometric properties of Italian norms for patients with mild cognitive impairment (PwMCI) and early dementia (PwD) and provided optimal cutoffs for diagnostic purposes.

Methods: Retrospective data collection was performed for consecutive patients with clinically and biologically defined MCI and early dementia. Forty-five patients (24 PwMCI and 21 PwD) and 25 healthy controls were included. Raw MoCA scores were adjusted according to the conventional 1-point correction (Nasreddine) and Italian norms (Conti, Santangelo, Aiello). The diagnostic properties of the original cutoff (< 26) and normative cutoffs, namely, the upper limits (uLs) of equivalent scores (ES) 1, 2, and 3, were evaluated. ROC curve analysis was performed to obtain optimal cutoffs.

Results: The original cutoff demonstrated high sensitivity (0.93 [95% CI 0.84-0.98]) but low specificity (0.44 [0.32-0.56]) in discriminating between patients and controls. Nominal normative cutoffs (ES0 uLs) showed excellent specificity (SP range = 0.96-1.00 [0.88-1.00]) but poor sensitivity (SE range = 0.09-0.24 [0.04-0.36]). The optimal cutoff for Nasreddine's method was 23.50 (SE = 0.82 [0.71-0.90]; SP = 0.72 [0.60-0.82]). Optimal cutoffs were 20.97, 22.85, and 22.29 (SE range = 0.69-0.73 [0.57-0.83], SP range = 0.88-0.92 [0.77-0.97]) for Conti's, Santangelo's, and Aiello's methods, respectively.

Conclusion: Using the 1-point correction, combined with a cutoff of 23.50, might be useful in ambulatory settings with a large turnout. Our optimal cutoffs can offset the poor sensitivity of Italian cutoffs.

Citing Articles

Resting-State EEG Power Spectral Density Analysis Between Healthy and Cognitively Impaired Subjects.

Walters K, Shukla R, Kumar V, Schueren S, Yadav H, Schilaty N Brain Sci. 2025; 15(2).

PMID: 40002506 PMC: 11853412. DOI: 10.3390/brainsci15020173.


Exploring apathy components and their relationship in cognitive decline: insights from a network cross-sectional study.

Sarti P, Varrasi S, Guerrera C, Platania G, Furneri G, Torre V BMC Psychol. 2025; 13(1):129.

PMID: 39962563 PMC: 11834197. DOI: 10.1186/s40359-024-02239-x.


Periodontal Indices as Predictors of Cognitive Decline: Insights from the PerioMind Colombia Cohort.

Arevalo-Caro C, Lopez D, Sanchez Milan J, Lorca C, Mulet M, Arboleda H Biomedicines. 2025; 13(1).

PMID: 39857789 PMC: 11760870. DOI: 10.3390/biomedicines13010205.


Deficits in reaching movements under visual interference as a novel diagnostic marker for mild cognitive impairment.

Ilardi C, Federico G, La Marra M, Amato R, Iavarone A, Soricelli A Sci Rep. 2025; 15(1):1901.

PMID: 39805990 PMC: 11730333. DOI: 10.1038/s41598-025-85785-7.


No matter how big it is, but how you use it: the importance of demographic adjustment in clinical neuropsychology.

Ilardi C, Menichelli A, Federico G, Salvatore M, Manganotti P Neurol Sci. 2024; 46(2):1027-1030.

PMID: 39436519 DOI: 10.1007/s10072-024-07831-y.


References
1.
Freitas S, Simoes M, Alves L, Santana I . Montreal Cognitive Assessment (MoCA): normative study for the Portuguese population. J Clin Exp Neuropsychol. 2011; 33(9):989-96. DOI: 10.1080/13803395.2011.589374. View

2.
Sachdev P, Kalaria R, OBrien J, Skoog I, Alladi S, Black S . Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014; 28(3):206-18. PMC: 4139434. DOI: 10.1097/WAD.0000000000000034. View

3.
Lee D, Seo S, Roh J, Oh M, Oh J, Oh S . Effects of Cognitive Reserve in Alzheimer's Disease and Cognitively Unimpaired Individuals. Front Aging Neurosci. 2022; 13:784054. PMC: 8859488. DOI: 10.3389/fnagi.2021.784054. View

4.
Franzen S, Watermeyer T, Pomati S, Papma J, Rune Nielsen T, Narme P . Cross-cultural neuropsychological assessment in Europe: Position statement of the European Consortium on Cross-Cultural Neuropsychology (ECCroN). Clin Neuropsychol. 2021; 36(3):546-557. DOI: 10.1080/13854046.2021.1981456. View

5.
Borland E, Nagga K, Nilsson P, Minthon L, Nilsson E, Palmqvist S . The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort. J Alzheimers Dis. 2017; 59(3):893-901. PMC: 5545909. DOI: 10.3233/JAD-170203. View